Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance.

PMID: 34979155
Journal: BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Year: 2022
Reference: Biochim Biophys Acta Rev Cancer. 2022 Jan;1877(1):188674. doi: 10.1016/j.bbcan.2021.188674. Epub 2021 Dec 31.
Impact factor: 10.68
Publication type: Review in international publication
Authors: Mir, Cristina; Carballo, Laia; Sanchez-Garcia, Almudena; Bataller, Marina; LLeonart, Matilde E; Garcia-Mayea, Yoelsis et al.
DOI: 10.1016/j.bbcan.2021.188674

TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance.

PMID: 34979155
Journal: BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Year: 2022
Reference: Biochim Biophys Acta Rev Cancer. 2022 Jan;1877(1):188674. doi: 10.1016/j.bbcan.2021.188674. Epub 2021 Dec 31.
Impact factor:
Publication type: Review in international publication
Authors: Bataller, Marina; Carballo, Laia; Garcia-Mayea, Yoelsis; LLeonart, Matilde E; Mir, Cristina; Sanchez-Garcia, Almudena et al.
DOI: 10.1016/j.bbcan.2021.188674

Tuberculosis Reactivation After Severe SARS-COV-2 Pneumonia.

PMID: 35550308
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2022
Reference: Arch Bronconeumol. 2022 Apr 27. pii: S0300-2896(22)00323-4. doi: 10.1016/j.arbres.2022.03.024.
Impact factor: 4.872
Publication type: Letter or abstract
Authors: De Souza-Galvao, Maria-Luiza, Jimenez-Fuentes, Maria-Angeles, Cardoso-Landivar, Jose et al.
DOI: 10.1016/j.arbres.2022.03.024

Tuberculosis Reactivation After Severe SARS-COV-2 Pneumonia.

PMID: 35550308
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2022
Reference: Arch Bronconeumol. 2022 Nov;58(11):764-765. doi: 10.1016/j.arbres.2022.03.024. Epub 2022 Apr 27.
Impact factor:
Publication type: Letter or abstract
Authors: Cardoso-Landivar, Jose; De Souza-Galvao, Maria-Luiza; Jimenez-Fuentes, Maria-Angeles et al.
DOI: 10.1016/j.arbres.2022.03.024

Tumor Cellularity and Infiltrating Lymphocytes (CelTIL) as a Survival Surrogate in HER2-Positive Breast Cancer.

PMID: 33787900
Journal: JNCI-Journal of the National Cancer Institute
Year: 2022
Reference: J Natl Cancer Inst. 2022 Mar 8;114(3):467-470. doi: 10.1093/jnci/djab057.
Impact factor: 13.506
Publication type: Paper in international publication
Authors: Chic, Nuria, Luen, Stephen J, Nuciforo, Paolo, Salgado, Roberto, Fumagalli, Debora, Hilbers, Florentine, Wang, Yingbo, de Azambuja, Evandro, Lang, Istvan, Di Cosimo, Serena et al.
DOI: 10.1093/jnci/djab057

Tumor Cellularity and Infiltrating Lymphocytes (CelTIL) as a Survival Surrogate in HER2-Positive Breast Cancer.

PMID: 33787900
Journal: JNCI-Journal of the National Cancer Institute
Year: 2022
Reference: J Natl Cancer Inst. 2022 Mar 8;114(3):467-470. doi: 10.1093/jnci/djab057.
Impact factor:
Publication type: Paper in international publication
Authors: Chic, Nuria; de Azambuja, Evandro; Di Cosimo, Serena; Fumagalli, Debora; Hilbers, Florentine; Huober, Jens; Lang, Istvan; Loi, Sherene; Luen, Stephen J; Nuciforo, Paolo et al.
DOI: 10.1093/jnci/djab057

Tumor Genomic Testing for >4000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib).

PMID: 35091440
Journal: CLINICAL CANCER RESEARCH
Year: 2022
Reference: Clin Cancer Res. 2022 Apr 14;28(8):1518-1530. doi: 10.1158/1078-0432.CCR-21-3940.
Impact factor: 12.531
Publication type: Paper in international publication
Authors: Poehlein, Christian, de Bono, Johann, Allen, Allison, Adelman, Carrie A, Kang, Jinyu, Elvin, Julia A, Hussain, Maha, Corcoran, Claire, Sibilla, Caroline, Fizazi, Karim et al.
DOI: 10.1158/1078-0432.CCR-21-3940

Tumor Genomic Testing for >4000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib).

PMID: 35091440
Journal: CLINICAL CANCER RESEARCH
Year: 2022
Reference: Clin Cancer Res. 2022 Apr 14;28(8):1518-1530. doi: 10.1158/1078-0432.CCR-21-3940.
Impact factor:
Publication type: Paper in international publication
Authors: Adelman, Carrie A; Allen, Allison; Choi, Young Deuk; Corcoran, Claire; de Bono, Johann; Elvin, Julia A; Fizazi, Karim; Gedye, Craig; Huisden, Robert; Hussain, Maha et al.
DOI: 10.1158/1078-0432.CCR-21-3940

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy.

PMID: 36171009
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Sep;10(9). pii: jitc-2022-005320. doi: 10.1136/jitc-2022-005320.
Impact factor:
Publication type: Paper in international publication
Authors: Barneto Aranda, Isidoro; Bernabe, Reyes; Calvo, Virginia; Casarrubios, Marta; Cobo, Manuel; Cruz-Bermudez, Alberto; De Castro Carpeno, Javier; Del Barco, Edel; Del Rosario Garcia-Campelo, Maria; Domine, Manuel et al.
DOI: 10.1136/jitc-2022-005320

Tumor Size and Oncological Outcomes in Patients with Early Cervical Cancer Treated by Fertility Preservation Surgery: A Multicenter Retrospective Cohort Study.

PMID: 35565238
Journal: Cancers
Year: 2022
Reference: Cancers (Basel). 2022 Apr 23;14(9). pii: cancers14092108. doi: 10.3390/cancers14092108.
Impact factor: 6.639
Publication type: Paper in international publication
Authors: Gil-Ibanez, Blanca, Gil-Moreno, Antonio, Torne, Aureli, Martin Jimenez, Angel, Gorostidi, Mikel, Zapardiel, Ignacio, Tejerizo Garcia, Alvaro, Diaz-Feijoo, Berta, On Behalf Of Sego Spain-Gog Cervical Cancer Task F et al.
DOI: 10.3390/cancers14092108

Tumor Size and Oncological Outcomes in Patients with Early Cervical Cancer Treated by Fertility Preservation Surgery: A Multicenter Retrospective Cohort Study.

PMID: 35565238
Journal: Cancers
Year: 2022
Reference: Cancers (Basel). 2022 Apr 23;14(9). pii: cancers14092108. doi: 10.3390/cancers14092108.
Impact factor:
Publication type: Paper in international publication
Authors: Diaz-Feijoo, Berta; Gil-Ibanez, Blanca; Gil-Moreno, Antonio; Gorostidi, Mikel; Martin Jimenez, Angel; On Behalf Of Sego Spain-Gog Cervical Cancer Task F; Tejerizo Garcia, Alvaro; Torne, Aureli; Zapardiel, Ignacio et al.
DOI: 10.3390/cancers14092108

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study.

PMID: 35326718
Journal: Cancers
Year: 2022
Reference: Cancers (Basel). 2022 Mar 18;14(6). pii: cancers14061568. doi: 10.3390/cancers14061568.
Impact factor: 6.639
Publication type: Paper in international publication
Authors: Touchefeu, Yann, Gkika, Eleni, Grosu, Anca-Ligia, Macarulla Mercade, Teresa, Cubillo Gracian, Antonio, Brunner, Thomas B, Schultheiss, Michael, Pazgan-Simon, Monika, Seufferlein, Thomas et al.
DOI: 10.3390/cancers14061568

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study.

PMID: 35326718
Journal: Cancers
Year: 2022
Reference: Cancers (Basel). 2022 Mar 18;14(6). pii: cancers14061568. doi: 10.3390/cancers14061568.
Impact factor:
Publication type: Paper in international publication
Authors: Brunner, Thomas B; Cubillo Gracian, Antonio; Gkika, Eleni; Grosu, Anca-Ligia; Macarulla Mercade, Teresa; Pazgan-Simon, Monika; Schultheiss, Michael; Seufferlein, Thomas; Touchefeu, Yann et al.
DOI: 10.3390/cancers14061568

Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer.

PMID: 34933155
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2022
Reference: Eur J Cancer. 2022 Jan;161:90-98. doi: 10.1016/j.ejca.2021.11.018. Epub 2021 Dec 18.
Impact factor: 9.162
Publication type: Paper in international publication
Authors: Lee, Jeeyun; Manca, Paolo; Bergamo, Francesca; Pagani, Filippo; Antista, Maria; Angerilli, Valentina; Ros Montana, Francisco Javier; Lavacchi, Daniele; Boccaccino, Alessandra; Fuca, Giovanni et al.
DOI: 10.1016/j.ejca.2021.11.018

Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer.

PMID: 34933155
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2022
Reference: Eur J Cancer. 2022 Jan;161:90-98. doi: 10.1016/j.ejca.2021.11.018. Epub 2021 Dec 18.
Impact factor:
Publication type: Paper in international publication
Authors: Angerilli, Valentina; Antista, Maria; Bergamo, Francesca; Boccaccino, Alessandra; Brich, Silvia; Cattaneo, Laura; Cremolini, Chiara; Elez, Elena; Fassan, Matteo; Fuca, Giovanni et al.
DOI: 10.1016/j.ejca.2021.11.018

Turnbull-Cutait pull-through technique for delayed coloanal anastomosis after ultralow rectal resection: a step-by-step video demonstration.

PMID: 35277909
Journal: Colorectal Disease
Year: 2022
Reference: Colorectal Dis. 2022 Mar 11. doi: 10.1111/codi.16114.
Impact factor: 3.788
Publication type: Letter or abstract
Authors: Pera, Meritxell, Barrios, Oriana, Pellino, Gianluca, Golda, Thomas, Biondo, Sebastiano, Espin-Basany, Eloy et al.
DOI: 10.1111/codi.16114

Turnbull-Cutait pull-through technique for delayed coloanal anastomosis after ultralow rectal resection: a step-by-step video demonstration.

PMID: 35277909
Journal: Colorectal Disease
Year: 2022
Reference: Colorectal Dis. 2022 Jul;24(7):889-890. doi: 10.1111/codi.16114. Epub 2022 Mar 24.
Impact factor:
Publication type: Letter or abstract
Authors: Barrios, Oriana; Biondo, Sebastiano; Espin-Basany, Eloy; Golda, Thomas; Pellino, Gianluca; Pera, Meritxell et al.
DOI: 10.1111/codi.16114

Turner syndrome and aortic complications: more benign than previously thought.

PMID: 36371658
Journal: HEART
Year: 2022
Reference: Heart. 2022 Dec 22;109(2):82-83. doi: 10.1136/heartjnl-2022-321330.
Impact factor:
Publication type: Editorail in international publication
Authors: Galian-Gay, Laura; Rodriguez-Palomares, Jose F et al.
DOI: 10.1136/heartjnl-2022-321330

Twenty twenty ... two: Headache and COVID-19.

PMID: 35670131
Journal: HEADACHE
Year: 2022
Reference: Headache. 2022 Jun;62(6):648-649. doi: 10.1111/head.14330. Epub 2022 Jun 7.
Impact factor: 5.887
Publication type: Letter or abstract
Authors: Pozo-Rosich, Patricia, Caronna, Edoardo et al.
DOI: 10.1111/head.14330

Twenty twenty ... two: Headache and COVID-19.

PMID: 35670131
Journal: HEADACHE
Year: 2022
Reference: Headache. 2022 Jun;62(6):648-649. doi: 10.1111/head.14330. Epub 2022 Jun 7.
Impact factor:
Publication type: Letter or abstract
Authors: Caronna, Edoardo; Pozo-Rosich, Patricia et al.
DOI: 10.1111/head.14330

Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry.

PMID: 35725623
Journal: Orphanet Journal of Rare Diseases
Year: 2022
Reference: Orphanet J Rare Dis. 2022 Jun 20;17(1):238. doi: 10.1186/s13023-022-02392-9.
Impact factor: 4.123
Publication type: Review in international publication
Authors: Beck, Michael, Ramaswami, Uma, Hernberg-Stahl, Elizabeth, Hughes, Derralynn A, Kampmann, Christoph, Mehta, Atul B, Nicholls, Kathleen, Niu, Dau-Ming, Pintos-Morell, Guillem, Reisin, Ricardo et al.
DOI: 10.1186/s13023-022-02392-9

Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry.

PMID: 35725623
Journal: Orphanet Journal of Rare Diseases
Year: 2022
Reference: Orphanet J Rare Dis. 2022 Jun 20;17(1):238. doi: 10.1186/s13023-022-02392-9.
Impact factor:
Publication type: Review in international publication
Authors: Anagnostopoulou, Christina; Beck, Michael; Botha, Jaco; Giugliani, Roberto; Hernberg-Stahl, Elizabeth; Hughes, Derralynn A; Kampmann, Christoph; Mehta, Atul B; Nicholls, Kathleen; Niu, Dau-Ming et al.
DOI: 10.1186/s13023-022-02392-9

[Twin gestation with complete hydatidiform mole and a coexisting live fetus: A case report and review of the literature].

PMID: 36075658
Journal: Revista espanola de patologia
Year: 2022
Reference: Rev Esp Patol. 2022 Sep;55 Suppl 1:S21-S26. doi: 10.1016/j.patol.2020.06.008. Epub 2020 Sep 2.
Impact factor:
Publication type: Review in national publication
Authors: Camacho, Jessica; Garcia-Ruiz, Itziar; Garrido-Pontnou, Marta; Madureira, Joana; Moscoso, Olivier; Navarro, Alexandra; Ramon Y Cajal, Santiago; Reques, Armando et al.
DOI: 10.1016/j.patol.2020.06.008

Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors.

PMID: 36108560
Journal: ESMO Open
Year: 2022
Reference: ESMO Open. 2022 Oct;7(5):100576. doi: 10.1016/j.esmoop.2022.100576. Epub 2022 Sep 13.
Impact factor:
Publication type: Paper in international publication
Authors: Becker, H; Claus, R; Elez, E; Fritsch, R; He, M; Hennequin, A; Isambert, N; Jayadeva, G; Le Tourneau, C; Luedtke, D et al.
DOI: 10.1016/j.esmoop.2022.100576